IFNG and neoplasm: At days 11 and 14, CD4+ and CD8+ tumor-infiltrating lymphocytes (TILs) were analyzed for Nr4a3-Timer, PD1, Lag3, and Ifng-YFP expression (Figures 6A–6D).